FDA Approves New Vaccine, Cervarix, for Prevention of Cervical Cancer
A News & Events entry posted on October 29, 2009
On October 16, FDA issued a press release announcing that it has approved Cervarix (GlaxoSmithKline) for use in girls and women ages 10 through 25 years to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV)types 16 and 18.
To view the entire press release visit the FDA Website
News Archive
- November 2011
- October 2011
- August 2011
- May 2011
- April 2011
- February 2011
- December 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- October 2009
- September 2009
- August 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- June 2008
Find us on Facebook
Follow us on Twitter